Munar Pharma

Munar Pharma EV/EBITDA

Delisted

The EV/EBITDA (Enterprise Value to EBITDA) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -47.33. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -11.62 — a change of 307.19% (lower).

EV/EBITDA

-47.33

YoY

307.19%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Munar Pharma is 2024 -47.33 . EV/EBITDA (Enterprise Value to EBITDA) of Munar Pharma was 2023 -11.62 . It decreases by 307.19% lower compared to the previous year.

The Munar Pharma EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2017
-88.84 PLN
Jan 1, 2018
-1.46 PLN
Jan 1, 2019
-215.27 PLN
Jan 1, 2020
-12.06 PLN
Jan 1, 2021
-16.36 PLN
Jan 1, 2022
94.50 PLN
Jan 1, 2023
-11.62 PLN
Jan 1, 2024
-47.33 PLN
The Munar Pharma EV/EBITDA history
YEAREV/EBITDAYoY
-47.33+307.19%
-11.62-112.30%
94.50-677.66%
-16.36+35.67%
-12.06-94.40%
-215.27+14,674.86%
-1.46-98.36%
-88.84-110.72%
828.67+106.83%
400.65—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

EV/EBITDA (Enterprise Value to EBITDA) of Munar Pharma is -47.33 in 2024.

EV/EBITDA (Enterprise Value to EBITDA) of Munar Pharma changed from -11.62 to -47.33, representing a 307.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Munar Pharma

All Key Metrics — Munar Pharma